A team of researchers has adapted their DNA nanoswitch technology -- previously demonstrated to aid drug discovery and the measure of biochemical interactions -- into a new platform that they call the nanoswitch-linked immunosorbent assay (NLISA) for fast, sensitive and specific protein detection.